Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00920010 · ClinicalTrials.gov registry record

S9925: Collecting and Storing Samples From Patients With Lung Cancer

A clinical trial of Lung Cancer, sponsored by SWOG Cancer Research Network.

Completed
Registry status
2,264
Enrollment target
20
Study locations

NCT00920010 is a study of Lung Cancer that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 2,264 participants, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (143% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00920010, a study of Lung Cancer, has completed, sponsored by SWOG Cancer Research Network.

COMPLETED
Registry status
2,264 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.

Conditions Studied

Interventions

  • OTHER biologic sample preservation procedure

Study Locations (20)

California

  • Kaiser Permanente - Deer Valley - Antioch
  • Alta Bates Summit Comprehensive Cancer Center - Berkeley
  • Providence Saint Joseph Medical Center - Burbank - Burbank
  • Peninsula Medical Center - Burlingame
  • East Bay Radiation Oncology Center - Castro Valley
  • Eden Medical Center - Castro Valley
  • Valley Medical Oncology Consultants - Castro Valley - Castro Valley
  • Cancer Care Center at John Muir Health - Concord Campus - Concord
  • North Bay Cancer Center - Fairfield
  • Kaiser Permanente - Fremont - Fremont
  • Valley Medical Oncology - Fremont
  • Washington Township Hospital - Fremont
  • California Cancer Center - Woodward Park Office - Fresno

Arkansas

  • Highlands Oncology Group - Springdale - Bentonville
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock

Alaska

  • Alaska Regional Hospital Cancer Center - Anchorage
  • Providence Cancer Center - Anchorage

Alabama

  • Providence Cancer Center at Providence Hospital - Mobile

Arizona

  • Arizona Cancer Center at University of Arizona Health Sciences Center - Tucson

Trial Details

FieldValue
Enrollment Target 2,264 participants
Start Date 2000-09
Est. Completion 2013-01

Sponsor

SWOG Cancer Research Network

270 total trials

What the Registry Record Tells You About NCT00920010

The ClinicalTrials.gov registry entry for NCT00920010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,264 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (143% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.

NCT00920010 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Arkansas, Alaska.

Frequently Asked Questions

What is clinical trial NCT00920010 about?

NCT00920010 is a clinical study titled "S9925: Collecting and Storing Samples From Patients With Lung Cancer". RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be t...

What is the current status of trial NCT00920010?

This trial is currently completed. The enrollment target is 2,264 participants. The study started on 2000-09. Estimated completion is 2013-01.

What conditions does trial NCT00920010 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00920010?

The interventions under investigation include: biologic sample preservation procedure (OTHER).

Who is sponsoring clinical trial NCT00920010?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00920010 being conducted?

This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.